Plasmacytoid dendritic cells in lymph nodes of patients with human immunodeficiency virus

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• Circulating plasmacytoid dendritic cells (PDC) decrease in human immunodeficiency virus (HIV) infection.
• Previous studies on nodal PDC in HIV have yielded variable results regarding their numbers.
• Understanding PDC behavior in lymph nodes is crucial for assessing HIV-related immune dysregulation.

Purpose of the Study:

• To investigate the relationship between nodal PDC clustering and key indicators of HIV infection.
• To correlate PDC distribution in lymph nodes with CD4 counts, HIV-lymphadenitis stage, and treatment duration.

Main Methods:

• Analysis of 28 archived lymph node biopsies from 25 HIV patients using CD123 immunostaining.
• Grading PDC clustering from 1 (none) to 4 (large tight clusters).
• Statistical correlation of PDC clustering with clinical parameters like CD4 counts and HIV-lymphadenitis stage.

Main Results:

• Increased PDC clustering in lymph nodes was significantly associated with lower blood CD4 counts (P = 0.001).
• Higher PDC clustering correlated with shorter treatment duration (P = 0.0268) and advancing HIV-lymphadenitis stage (P = 0.06).
• No significant correlation was found between nodal PDC clustering and time since HIV diagnosis.

Conclusions:

• Findings suggest a redistribution of PDC to lymph nodes in HIV infection, particularly with advancing immunodeficiency.
• Nodal PDC clustering serves as a potential biomarker for disease progression and immune status in HIV patients.
• This study provides novel insights into the in-situ behavior of PDC within lymph nodes during HIV infection.